Oriola Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 31, 2023 at 02:30 am EDT
Share
Oriola Oyj reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EUR 352.6 million compared to EUR 373.9 million a year ago. Net loss was EUR 20.2 million compared to net income of EUR 14.6 million a year ago. Basic loss per share from continuing operations was EUR 0.11 compared to basic earnings per share from continuing operations of EUR 0.03 a year ago. Diluted loss per share from continuing operations was EUR 0.11 compared to diluted earnings per share from continuing operations of EUR 0.03 a year ago. Basic loss per share was EUR 0.11 compared to basic earnings per share of EUR 0.08 a year ago. Diluted loss per share was EUR 0.11 compared to diluted earnings per share of EUR 0.08 a year ago.
For the nine months, sales was EUR 1,090.9 million compared to EUR 1,141.3 million a year ago. Net loss was EUR 17.9 million compared to net income of EUR 35.5 million a year ago. Basic loss per share from continuing operations was EUR 0.1 compared to basic earnings per share from continuing operations of EUR 0.07 a year ago. Diluted loss per share from continuing operations was EUR 0.1 compared to diluted earnings per share from continuing operations of EUR 0.07 a year ago. Basic loss per share was EUR 0.1 compared to basic earnings per share of EUR 0.2 a year ago. Diluted loss per share was EUR 0.1 compared to diluted earnings per share of EUR 0.2 a year ago.
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.